ArticleJournal of experimental & clinical cancer research : CR2023
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
E C de Heer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.